Lyell Immunopharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Lyell Immunopharma Inc
CIK #0001806952
EDGAR Form CIK 2011 - 2026
10-K [0001806952]
10-Q [0001806952]
3 [0001806952]
4 [0001806952]
8-K [0001806952]
D [0001806952]
SC 13G [0001806952]
Form 13D/13G Filer Form 13D/13G Subject Filed
Euler Fund LP Lyell Immunopharma Inc [2026-04-21]
Innovative Cellular Therapeutics Holdings Ltd Lyell Immunopharma Inc [2025-11-13]
Explore Investments LLC/De Lyell Immunopharma Inc [2025-08-19]
Gates Frontier LLC Lyell Immunopharma Inc [2025-08-01]
Foresite Capital Fund IV LP Lyell Immunopharma Inc [2024-10-31]
BlackRock Inc Lyell Immunopharma Inc [2024-01-29]
Vanguard Group Inc Lyell Immunopharma Inc [2023-02-09]
MWG Management Ltd Lyell Immunopharma Inc [2022-02-14]
Newton PTC Ltd Lyell Immunopharma Inc [2022-02-14]
Arch Venture Fund IX LP Lyell Immunopharma Inc [2022-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Innovative Cellular Therapeutics Holdings Ltd
Lyell Immunopharma Inc
Hill Stephen J
Lee Gary K
Bulis Veronica Sanchez
Seely Lynn
Ramachandra Sumant
Friedman Cathy
Rieflin William JL
Bachleda Mark
Nabel Elizabeth G
Klausner Richard
Brawley Otis W
Shook David
Shah Smital
Bybee Clinton
Arch Venture Partners XIII LLC
Berns Paul L
Burow Kristina
Arch Venture Partners XIII LP
Arch Venture Fund XIII LP
Nelsen Robert
Gillis Steven
Crandell Keith
Arch Venture Partners IX LLC
Arch Venture Partners IX Overage LP
Arch Venture Fund IX Overage LP
Arch Venture Partners IX LP
Arch Venture Fund IX LP
Meltz Mark A
Newton Charles W
Lang Matthew
Bishop Hans Edgar
Thompson Rahsaan
Albertson Tina M
Turner Heather D
Homans Elizabeth
GlaxoSmithKline PLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2026-03-09 Grant 140,000 $0.00
Lyell Immunopharma Inc LYEL
Common Stock
2026-03-06 Buy 488,090 $25.61 12,499,985
Lyell Immunopharma Inc LYEL
Common Stock
2026-03-06 Buy 488,090 $25.61 12,499,985
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-11 Sell 1,236 $23.39 28,910
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-11 Sell 1,671 $23.39 39,085
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-11 Sell 7,455 $23.39 174,372
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2026-02-10 Grant 155,000 $0.00
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-10 Sell 109 $23.12 2,520
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-10 Sell 147 $23.12 3,399
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-10 Sell 438 $23.12 10,127
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-10 Sell 254 $23.12 5,872
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-10 Grant 8,750 $0.00
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2026-02-10 Grant 65,000 $0.00
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2026-02-10 Grant 50,000 $0.00
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2026-02-10 Grant 50,000 $0.00
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2026-02-10 Grant 50,000 $0.00
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-09 Grant 4,000 $0.00
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-09 Grant 20,000 $0.00
Lyell Immunopharma Inc LYEL
Common Stock
2026-02-09 Grant 4,000 $0.00
Lyell Immunopharma Inc LYEL
Common Stock
2025-12-30 Sell 936 $32.32 30,252
showing 20 of 172 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com